project id: TCGA-STAD; case submitter id: TCGA-BR-A4PF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 7.9; age at index: 72; days to birth: -26412; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 26412; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 35.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 176; days to sample procurement: 0; initial weight: 1100.0; portion submitter id: TCGA-BR-A4PF-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 100.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;